These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 12423628

  • 1. Effects of lowering circulating free fatty acid levels on protein metabolism in adult growth hormone deficient patients.
    Nielsen S, Jørgensen JO, Hartmund T, Nørrelund H, Nair KS, Christiansen JS, Møller N.
    Growth Horm IGF Res; 2002 Dec; 12(6):425-33. PubMed ID: 12423628
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of lipolysis during acute GH exposure increases insulin sensitivity in previously untreated GH-deficient adults.
    Segerlantz M, Bramnert M, Manhem P, Laurila E, Groop LC.
    Eur J Endocrinol; 2003 Dec; 149(6):511-9. PubMed ID: 14640991
    [Abstract] [Full Text] [Related]

  • 3. Restoration of growth hormone (GH) response to GH-releasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids.
    Pontiroli AE, Manzoni MF, Malighetti ME, Lanzi R.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3998-4001. PubMed ID: 8923850
    [Abstract] [Full Text] [Related]

  • 4. The effect of long-term pharmacological antilipolysis on substrate metabolism in growth hormone (GH)-substituted GH-deficient adults.
    Nielsen S, Møller N, Pedersen SB, Christiansen JS, Jørgensen JO.
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3274-8. PubMed ID: 12107236
    [Abstract] [Full Text] [Related]

  • 5. The decisive role of free fatty acids for protein conservation during fasting in humans with and without growth hormone.
    Nørrelund H, Nair KS, Nielsen S, Frystyk J, Ivarsen P, Jørgensen JO, Christiansen JS, Møller N.
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4371-8. PubMed ID: 12970312
    [Abstract] [Full Text] [Related]

  • 6. Dose-response effects of free fatty acids on amino acid metabolism and ureagenesis.
    Gormsen LC, Gjedsted J, Gjedde S, Nørrelund H, Christiansen JS, Schmitz O, Jørgensen JO, Møller N.
    Acta Physiol (Oxf); 2008 Mar; 192(3):369-79. PubMed ID: 17973949
    [Abstract] [Full Text] [Related]

  • 7. Effect of acipimox, a lipid lowering drug, on growth hormone (GH) response to GH-releasing hormone in normal subjects.
    Pontiroli AE, Lanzi R, Monti LD, Pozza G.
    J Endocrinol Invest; 1990 Jun; 13(6):539-42. PubMed ID: 2258583
    [Abstract] [Full Text] [Related]

  • 8. Acipimox-mediated plasma free fatty acid depression per se stimulates growth hormone (GH) secretion in normal subjects and potentiates the response to other GH-releasing stimuli.
    Peino R, Cordido F, Peñalva A, Alvarez CV, Dieguez C, Casanueva FF.
    J Clin Endocrinol Metab; 1996 Mar; 81(3):909-13. PubMed ID: 8772549
    [Abstract] [Full Text] [Related]

  • 9. Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression.
    Cordido F, Peino R, Peñalva A, Alvarez CV, Casanueva FF, Dieguez C.
    J Clin Endocrinol Metab; 1996 Mar; 81(3):914-8. PubMed ID: 8772550
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of the rise in FFA by Acipimox partially prevents GH-induced insulin resistance in GH-deficient adults.
    Segerlantz M, Bramnert M, Manhem P, Laurila E, Groop LC.
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5813-8. PubMed ID: 11739444
    [Abstract] [Full Text] [Related]

  • 11. Acipimox potentiates growth hormone response to growth hormone-releasing hormone by decreasing serum free fatty acid levels in hyperthyroidism.
    Lee EJ, Kim KR, Lee HC, Cho JH, Nam MS, Nam SY, Song YD, Lim SK, Huh KB.
    Metabolism; 1995 Nov; 44(11):1509-12. PubMed ID: 7476342
    [Abstract] [Full Text] [Related]

  • 12. Evidence for an inhibitory effect of physiological levels of insulin on the growth hormone (GH) response to GH-releasing hormone in healthy subjects.
    Lanzi R, Manzoni MF, Andreotti AC, Malighetti ME, Bianchi E, Sereni LP, Caumo A, Luzi L, Pontiroli AE.
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2239-43. PubMed ID: 9215300
    [Abstract] [Full Text] [Related]

  • 13. Effects of GH replacement therapy in adults on serum levels of leptin and ghrelin: the role of lipolysis.
    Vestergaard ET, Hansen TK, Nielsen S, Moller N, Christiansen JS, Jorgensen JO.
    Eur J Endocrinol; 2005 Oct; 153(4):545-9. PubMed ID: 16189176
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure.
    Nielsen S, Møller N, Christiansen JS, Jørgensen JO.
    Diabetes; 2001 Oct; 50(10):2301-8. PubMed ID: 11574412
    [Abstract] [Full Text] [Related]

  • 15. Effects of 3-hydroxybutyrate and free fatty acids on muscle protein kinetics and signaling during LPS-induced inflammation in humans: anticatabolic impact of ketone bodies.
    Thomsen HH, Rittig N, Johannsen M, Møller AB, Jørgensen JO, Jessen N, Møller N.
    Am J Clin Nutr; 2018 Oct 01; 108(4):857-867. PubMed ID: 30239561
    [Abstract] [Full Text] [Related]

  • 16. Long-term administration of acipimox potentiates growth hormone response to growth hormone-releasing hormone by decreasing serum free fatty acid in obesity.
    Nam SY, Lee, Kim KR, Lee HC, Nam MS, Cho JH, Huh KB.
    Metabolism; 1996 May 01; 45(5):594-7. PubMed ID: 8622602
    [Abstract] [Full Text] [Related]

  • 17. The impact of forearm immobilization and acipimox administration on muscle amino acid metabolism and insulin sensitivity in healthy, young volunteers.
    Dirks ML, Jameson TSO, Andrews RC, Dunlop MV, Abdelrahman DR, Murton AJ, Wall BT, Stephens FB.
    Am J Physiol Endocrinol Metab; 2024 Mar 01; 326(3):E277-E289. PubMed ID: 38231001
    [Abstract] [Full Text] [Related]

  • 18. Effect of acute reduction of free fatty acids by acipimox on growth hormone-releasing hormone-induced GH secretion in type 1 diabetic patients.
    Alvarez P, Isidro L, Peinó R, Leal-Cerro A, Casanueva FF, Dieguez C, Cordido F.
    Clin Endocrinol (Oxf); 2003 Oct 01; 59(4):431-6. PubMed ID: 14510904
    [Abstract] [Full Text] [Related]

  • 19. Acipimox potentiates growth hormone (GH) response to GH-releasing hormone with or without pyridostigmine by lowering serum free fatty acid in normal and obese subjects.
    Lee EJ, Nam SY, Kim KR, Lee HC, Cho JH, Nam MS, Song YD, Lim SK, Huh KB.
    J Clin Endocrinol Metab; 1995 Aug 01; 80(8):2495-8. PubMed ID: 7629249
    [Abstract] [Full Text] [Related]

  • 20. Modulation of basal glucose metabolism and insulin sensitivity by growth hormone and free fatty acids during short-term fasting.
    Nørrelund H, Nielsen S, Christiansen JS, Jørgensen JO, Møller N.
    Eur J Endocrinol; 2004 Jun 01; 150(6):779-87. PubMed ID: 15191347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.